Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
3
×
cancer immunotherapy
3
×
life sciences
national
national blog main
bristol-myers squibb
novartis
samit hirawat
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
clinical trials
crispr therapeutics
crispr-cas9
deals
denali therapeutics
detroit blog main
detroit top stories
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
gene editing
genmab
ido inhibitors
incyte
indiana blog main
indiana top stories
investing
johnson & johnson
joseph payne
What
clinical
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
year
ahead
ambien
american
annual
asco
attendees
attention
biotech
camp’s
cancer
cash
chicago
city
combinations
community’s
days
drug
Language
unset
Current search:
cancer
×
clinical
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
